GlassScriptPhysician profile
Mark Jefferson Rivera
NPI 1780045682
$1,576.48
in general payments reported to CMS, 2019-2025
24 companies · $21.26 in 2025
The $21.26 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $451 · 2023: $13.87 · 2024: $28.96 · 2025: $21.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $288.09 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $215.83 | 2019-2020 | |
| Amarin Pharma, INC. | $129.24 | 2019-2020 | |
| Abbvie INC. | $123.87 | 2019 | |
| Lilly USA, LLC | $117.00 | 2019-2020 | |
| Novo Nordisk INC | $97.94 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $88.06 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $86.22 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $75.05 | 2019-2020 | |
| Pfizer INC. | $51.42 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.74 | 2019 | |
| Abiomed | $28.96 | 2024 | Impella |
| Radius Health, INC. | $25.05 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.14 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $21.26 | 2025 | Cologuard Collection Kit |
| Ultragenyx Pharmaceutical INC. | $20.73 | 2020 | |
| Genentech USA, INC. | $19.24 | 2019 | |
| Glaxosmithkline, LLC. | $16.30 | 2019 | |
| Corcept Therapeutics | $14.05 | 2019 | |
| Baxter Healthcare | $13.87 | 2023 | Hillrom - Life 2000 Ventilation System |
| Abbott Laboratories | $13.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.00 | 2019 | |
| Zyla Life Sciences, INC. | $12.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.